ASCENTAGE PHARMA GR-ADR (AAPG) Stock Analyst Earnings Estimates
NASDAQ:AAPG - Nasdaq - ADR - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 27.91M 124.18% | 209.711M 651.38% | 221.984M 5.85% | 950.4M 328.14% | 539.57M -43.23% | 2.626B 386.68% | 2.311B -12.00% | 2.265B -1.99% | 2.944B 29.98% | 2.744B -6.79% | 3.236B 17.93% | 3.736B 15.45% | |
| EBITDA YoY % growth | -864.92M -30.98% | -791.464M 8.49% | -796.726M -0.66% | -264.034M 66.86% | -745.742M -182.44% | 526.96M 170.66% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -893.246M -29.88% | -852.935M 4.51% | -874.038M -2.47% | -270.526M 69.05% | -833.137M -207.97% | 977.94M 217.38% | 281.97M -71.17% | 180M -36.16% | 660.23M 266.79% | 730.14M 10.59% | 1.261B 72.71% | 1.759B 39.49% | |
| Operating Margin | -3,200.45% | -406.72% | -393.74% | -28.46% | -154.41% | 37.24% | 12.20% | 7.95% | 22.43% | 26.61% | 38.97% | 47.08% | |
| EPS YoY % growth | N/A 12.67% | N/A -6.38% | N/A 12.05% | -3.68 61.78% | -10.05 -173.23% | 11.00 209.46% | N/A | N/A | N/A | N/A | N/A | N/A |
All data in CNY
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CNY
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | 823.746M 477.25% | % | ||
| Q4 2023 Q2Q % growth | 79.283M -30.42% | % | ||
| Q2 2023 Q2Q % growth | 142.701M 49.01% | % | ||
| Q4 2022 Q2Q % growth | 113.948M 662.45% | % | ||
| Q2 2022 Q2Q % growth | 95.763M 638.63% | % | ||
| Q4 2021 Q2Q % growth | 14.945M 51.93% | % | ||
| Q2 2021 Q2Q % growth | 12.965M 396.17% | % | ||
| Q4 2020 Q2Q % growth | 9.837M -19.34% | % | ||
| Q2 2020 Q2Q % growth | 2.613M 12.78% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |